13 Approved ADCs in a Billion-Dollar Market: Why Are ADCs the New Favorite in Cancer Treatment?
Abstract: Antibody-drug conjugates (ADCs) are the star therapy in the field of cancer treatment today, combining the targeting ability of monoclonal antibodies with the cytotoxicity of small molecule drugs, effectively striking tumor cells like “precision missiles”.This article starts with the basic structure and mechanism of action of ADCs, analyzes the challenges faced in clinical applications, … Read more